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U11 and U12 interact cooperatively with the 50 splice site
and branch site of pre-mRNA as a stable preformed
di-snRNP complex, thereby bridging the 50 and 30 ends
of the intron within the U12-dependent prespliceosome.
To identify proteins contributing to di-snRNP formation
and intron bridging, we investigated protein–protein and
protein–RNA interactions between components of the U11/
U12 snRNP. We demonstrate that the U11/U12-65K protein
possesses dual binding activity, interacting directly with
U12 snRNA via its C-terminal RRM and the U11-associated
59K protein via its N-terminal half. We provide evidence
that, in contrast to the previously published U12 snRNA
secondary structure model, the 30 half of U12 forms an
extended stem-loop with a highly conserved seven-nucleo-
tide loop and that the latter serves as the 65K binding site.
Addition of an oligonucleotide comprising the 65K binding
site to an in vitro splicing reaction inhibited U12-depen-
dent, but not U2-dependent, pre-mRNA splicing. Taken
together, these data suggest that U11/U12-65K and U11-
59K contribute to di-snRNP formation and intron bridging
in the minor prespliceosome.
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Introduction
Two spliceosomes, the multi-subunit complexes that catalyze
pre-mRNA splicing, have been identified in higher eukaryotes
(Burge et al, 1999). The U2-dependent (major) spliceosome is
found in all eukaryotes and excises U2-type introns, which
represent the vast majority of pre-mRNA introns. The U12-
dependent (minor) spliceosome is found in only a subset of
organisms and removes U12-type introns, which constitute
less than 1% of introns in humans (Burge et al, 1998; Levine
and Durbin, 2001). In contrast to U2-type introns, they
contain highly conserved sequences at their 50 splice site
and branch site, but lack a polypyrimidine tract upstream of
the 30 splice site (Burge et al, 1998). U12-type introns coexist
with U2-type introns within the same gene, but are spliced
more slowly, indicating that U12-type splicing is a rate-deter-
mining step in gene expression (Patel et al, 2002). The U12-
dependent spliceosome contains the U11, U12, U5 and U4atac/
U6atac snRNPs, whereas the U2-dependent spliceosome con-
sists of the U1, U2, U5 and U4/U6 snRNPs (reviewed by Patel
and Steitz, 2003). U11, U12 and U4atac/U6atac have been
shown to be functional analogs of U1, U2 and U4/U6, respec-
tively (Hall and Padgett, 1996; Tarn and Steitz, 1996a, b;
Kolossova and Padgett, 1997; Yu and Steitz, 1997).
The assembly pathways of both spliceosomes are very
similar, with major differences occurring only during the
earliest stages (Patel and Steitz, 2003). Major spliceosome
assembly is initiated by interaction of U1 with the 50 splice
site, followed by the stable interaction of U2 with the branch
site, forming the so-called prespliceosome. Subsequent entry
of the U4/U6.U5 tri-snRNP triggers structural rearrangements
that lead to catalytic activation of the spliceosome. Formation
of the U12-type prespliceosome is initiated by association of
the U11 and U12 snRNPs, which, in contrast to U1 and U2,
bind as a highly stable, preformed di-snRNP. U11 and U12
recognize the 50 splice site and branch site, respectively, in a
cooperative manner (Frilander and Steitz, 1999). A catalyti-
cally active U12-type spliceosome is formed after integration
of the U4atac/U6atac.U5 tri-snRNP and subsequent confor-
mational changes (Tarn and Steitz, 1996b; Yu and Steitz,
1997; Frilander and Steitz, 2001). The excision of both types
of introns occurs via two successive transesterification reac-
tions, and an analogous, dynamic network of snRNA–snRNA
and snRNA–pre-mRNA interactions is formed in both splicing
machineries (Patel and Steitz, 2003).
Spliceosome assembly and splicing catalysis require the
activity of numerous proteins, as well as the formation of an
extensive network of RNA/protein and protein/protein inter-
actions. The major spliceosome is well characterized in terms
of its protein composition, with over 150 proteins identified
by mass spectrometry (reviewed by Jurica and Moore, 2003).
Insight into the protein composition of the minor spliceosome
is now slowly emerging. Many proteins appear to be shared
by both spliceosomes, including most U4/U6.U5 tri-snRNP
proteins (Luo et al, 1999; Nottrott et al, 2002; Schneider et al,
2002), the U2-associated complex SF3b (Will et al, 1999,
2004) and SR proteins (Hastings and Krainer, 2001). Recently,
the human U11/U12 di-snRNP particle was shown to contain
not only SF3b and Sm proteins, but also seven novel proteins
(denoted 65K, 59K, 48K, 35K, 31K, 25K and 20K) not found
in U2-type spliceosomes (Will et al, 2004). Four of these
proteins (59K, 48K, 35K and 25K) are U11 associated and thus
potentially facilitate the U11/50 splice site interaction.
The existence of unique U11/U12 proteins indicates
that many interactions contributing to minor prespliceo-
some formation, in particular those mediating 50 splice site
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recognition and intron bridging, differ from those in the
major prespliceosome. To date, little is known about protein–
protein interactions juxtaposing the ends of U12-type introns.
As U11 and U12 bind in the form of a stable di-snRNP to the 50
and 30 ends of U12-type introns, U11/U12-specific proteins have
been proposed to be involved in intron bridging interactions in
the minor prespliceosome. During the earliest step of major
spliceosome assembly, a molecular bridge is formed between
U1 at the 50 splice site and SF1/mBBP and U2AF, which bind to
the branch site and the polypyrimidine tract, respectively
(reviewed by Reed, 1996). SR proteins play a major role in
intron bridging at this stage, binding the U1-70K protein and
U2AF. Upon association of U2 with the branch site, SF1/mBBP
is displaced and a new set of interactions is thought to mediate
intron bridging in the major prespliceosome. The DEAD-box
protein Prp5 appears to play a role in bridging the U1 and U2
snRNPs (Xu et al, 2004). However, the precise nature of the
molecular bridge juxtaposing the reactive groups of U2-type
pre-mRNAs at this stage is not clear.
At present, little is known about the molecular architecture
of the U11/U12 di-snRNP, including which of the U11/U12
proteins contact the U11 and U12 snRNAs. Candidate snRNA
binding proteins include the U11/U12-65K, -35K and -31K
proteins, which contain one or more RNA recognition motifs
(RRMs), a structurally well-characterized domain found in a
large family of RNA binding proteins (Birney et al, 1993). The
RRM contains two highly conserved submotifs, the RNP-1
octamer and RNP-2 hexamer, and has a babbab structure that
folds into a four-stranded antiparallel b-sheet that packs
against the two a-helices (reviewed by Varani and Nagai,
1998). Protein–protein interactions within the U11/U12
snRNP, which potentially mediate di-snRNP formation and/
or intron bridging, also remain to be elucidated. Here we
have investigated the protein and RNA binding properties of
polypeptides of the U11/U12 di-snRNP. These studies provide
the first information regarding intermolecular interactions
within the U11/U12 snRNP and reveal potential players in
di-snRNP formation.
Results
The 65K protein interacts with U12 snRNA via
its C-terminal RRM
The human U11/U12-65K protein contains an N- and
C-terminal RRM and a centrally located proline-rich region
(Figures 1 and 2B). Database searches revealed likely 65K
Figure 1 The U11/U12-65K protein is evolutionarily conserved. Sequence alignment of the H. sapiens U11/U12-65K protein (gi|48427628) with
putative orthologs from M. musculus (gi|31981077), X. laevis (deduced from ESTs gi|26035864 and gi|17496030; note that the 50 end appears to
be incomplete), A. thaliana (gi|15217461) and D. melanogaster (gi|21626517). Residues identical in at least three proteins are highlighted in
black and conserved residues (gray) are grouped as follows: (D, E), (K, R), (A, S, T, G, C), (N, Q), (Y, F, M, H), (I, L, M, V) and (P). RRMs are
indicated by a bar. The conserved sequence QVLHLMN(K/R)MNL is marked by dots.
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orthologs in a variety of organisms known to contain U12-
type introns. An alignment of a subset of these (Figure 1)
revealed that the majority of sequence conservation lies
within the RRMs, with the C-terminal RRM exhibiting higher
homology than its N-terminal counterpart—that is, 64%
(amino acids (aa) 27–102) versus 49% (aa 420–503) when
comparing human with Arabidopsis thaliana. In Drosophila
melanogaster, the N-terminal region has diverged so
significantly that it no longer is recognized as an RRM by
motif search programs. A 100% conserved sequence,
QVLHLMN(K/R)MNL (aa 185–195 in humans), is found
downstream of the N-terminal RRM and is detected only in
putative 65K orthologs in the nonredundant (nr) database of
the National Center for Biotechnology Information (NCBI).
To test whether 65K directly binds U11 and/or U12 snRNA,
we translated 35S-labeled 65K protein in vitro and assayed
its interaction with in vitro-transcribed, m7G-capped U1, U2,
U11 and U12 snRNA. RNA was precipitated with anti-cap
antibodies and co-immunoprecipitation (co-IP) of 65K was
analyzed by SDS–PAGE. Whereas the level of 65K co-preci-
pitated with U1, U2 and U11 did not exceed background
(Figure 2A, cf. lanes 2–4 and 6), 65K was clearly co-precipi-
tated with U12 snRNA (lane 5). We next overexpressed 65K
as a GST fusion and performed GST pulldowns with 32P-
labeled U1, U2, U11 or U12 snRNA. No co-precipitation
was observed with GST alone (Figure 2D and E, lanes 5–8).
In contrast, a significant amount of U12 (B49%) and only
a low level of U1, U2 and U11 (B1–4%) co-precipitated with
GST-65K (Figure 2C, lanes 2–5; Figure 2E, lanes 9–12). Thus,
65K specifically binds the U12 snRNA.
To determine which RRM of 65K binds U12, several dele-
tion mutants were created (Figure 2B) and expressed as GST
fusion proteins. These include mutants containing the
N-terminal RRM plus C-terminal extensions of 48 aa (65-N-
RRM) or 155 aa (65K-N-half), and those possessing the
C-terminal RRM plus N-terminal extensions of 40 aa (65K-C-
RRM) or 209 aa (65K-C-half). Pulldown of U12 snRNA
was observed with GST-65K-C-half and GST-65K-C-RRM
(Figure 2C, lane 9; Figure 2D, lane 12), but not with GST
alone or GST-65K-N-RRM (Figure 2E, lanes 8 and 16), or only
to a low level with GST-65K-N-half (Figure 2E, lane 20).
Enhanced precipitation of U11 snRNA was observed with
Figure 2 65K binds U12 snRNA via its C-terminal RRM. (A) 35S-labeled, in vitro-translated 65K was incubated with in vitro-transcribed, m7G-
capped U1, U2, U11 or U12 snRNA (lanes 2–5, as indicated) or no RNA (lane 6) and co-IPs with anti-cap antibodies were performed as described
in Materials and methods. Lane 1: 20% of input 65K. (B) Schematic of 65K deletion mutants used in GST pulldowns. RRMs and the proline-rich
region (Pro) are shaded in gray and the QVLHLMN(K/R)MNL conserved motif in black. (C–E) GST pulldowns of in vitro-transcribed, 32P-labeled
UsnRNAs (indicated above each lane) by GST-65K wild-type or deletion mutants (as indicated). (C) Lane 1: 30% of a mixture of input snRNAs.
(D, E) Lanes 1–4: 30 or 10% of each input snRNA. RNAs were separated by denaturing PAGE and visualized by autoradiography.
Dual binding activity of the U11/U12-65K protein
H Benecke et al
&2005 European Molecular Biology Organization The EMBO Journal VOL 24 | NO 17 | 2005 3059
GST-65K-N-half (Figure 2E, lane 19) but no other deletion
mutant (Figure 2C, lane 8; Figure 2D, lane 11; Figure 2E, lane
15). However, as precipitation of U11 was not observed with
full-length 65K, and 65K is not a component of U11 mono-
particles (Will et al, 2004), U11 binding does not appear to be
a property of the wild-type protein. Upon truncation of 65K to
within 40 aa of the C-terminal RRM (65K-C-RRM), binding
specificity was lost to some extent; both U1 and U2, but
not U11, were also efficiently precipitated (Figure 2D, lanes
9–12). Likewise, in electrophoretic mobility shift assays
(EMSA), GST-65K-C-RRM interacted with U12, U1 and U2,
but not U11, U4 or U5 (not shown). These results indicate
that residues 211–380 contribute to 65K binding specificity.
Indeed, the N- and C-terminal extensions of RRMs often
play important roles in the specificity of RNA recognition
(reviewed by Varani and Nagai, 1998). Taken together, we
conclude that 65K directly binds the U12 snRNA via its
C-terminal RRM.
The C-terminal RRM of 65K and N-terminal RRM
of U1-A /U2-B 00 are highly homologous
The ability of 65K-C-RRM to additionally bind both U1 and
U2 (but not other snRNAs) suggests that 65K may be evolu-
tionarily related to the U1 snRNP A protein (U1-A) and the U2
snRNP B00 protein (U2-B0 0). These proteins are highly related
at the amino-acid sequence level and, similar to 65K, both
contain N- and C-terminal RRMs (Figure 3A). However, in
contrast to 65K, both U1-A and U2-B00 bind their cognate
snRNAs (i.e., U1 stem-loop (SL) II and U2 SLIV, respectively)
via their N-terminal RRMs (Varani and Nagai, 1998 and
Figure 3 The C-terminal RRM of 65K is homologous to the N-terminal RRM of U1-A and U2-B00. (A) Domain structure of the human 65K, U1-A
and U2-B00 proteins. (B) Sequence alignment of the C-terminal RRM of 65K (nt 420–503) and the N-terminal RRMs of U1-A (nt 10–89) and U2-B00
(nt 7–86). Identical amino acids are highlighted in black and conserved residues are grouped as in Figure 1. Secondary structure elements
according to the atomic structures of U1-A and U2-B00 are indicated below.
Figure 4 The 65K protein binds the 30 half of the U12 snRNA. (A) Co-IPs were performed as described in the legend to Figure 2 with 35S-labeled
65K and m7G-capped U11 (lane 2), U12 (lane 3) or U12 deletion mutants 50 half, DSLIV, SLIII or 30 half (lanes 4–7) or no RNA (lane 8).
(B) Structure of wild-type and truncated U12 snRNAs (according to Wassarman and Steitz, 1992). 50 half: nt 1–104; DSLIV: nt 1–130; SLIII:
nt 79–122; 30 half: nt 79–150. Digestion sites generating 50 half and DSLIV are indicated by an arrow and nucleotides (104–130) required
for 65K binding are indicated by a line.
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references therein). Intriguingly, aside from 65K orthologs,
the C-terminal RRM of human 65K shares one of the highest
degrees of homology (i.e., 50%) with the N-terminal RRM
of U1-A and U2-B00 from various organisms, when BLAST
searches are performed with the NCBI nr database. The RNP-
1 and RNP-2 submotifs of those RRMs of 65K and U1-A/U2-
B00 known to bind RNA are highly conserved (Figure 3B); only
the last two residues of RNP-1 and the fourth residue of
RNP-2 are not conserved, and all three proteins contain a
glutamine (Q) at the third position of their RNP-1 motif
as opposed to an aromatic residue typically found in the
vast majority of RNP-1 motifs (Birney et al, 1993 and
references therein). Thus, it is conceivable that the C-terminal
RRM of 65K may have diverged from the N-terminal RRM of
U1-A/U2-B00 or vice versa.
65K binds the 3 0 half of the U12 snRNA
The proposed structure of human U12 (Figure 4B) resembles
that of U2 snRNA. Three SLs in its 50 half (designated I, IIa
and IIb) are separated from SLIII and IV by the single-
stranded Sm site. To map the binding site of 65K, we
performed co-IPs with 35S-labeled 65K and in vitro-tran-
scribed m7G-capped deletion mutants of human U12
(Figure 4). Deletion of 19 nucleotides (nt) from the 30 end
(mutant DSLIV), which disrupts SLIV, had no effect on 65K
binding (Figure 4A, cf. lanes 3 and 5). However, truncation to
nt 103 (mutant 50 half), which leads to the loss of both SLIII
and IV, reduced 65K binding to background levels (cf. lanes 4
and 8), suggesting that SLIII is required for 65K interaction.
Surprisingly, a U12 snRNA consisting solely of SLIII did not
support 65K binding (lane 6). In contrast, when both SLIII
and IV were present (30 half), wild-type binding of 65K was
observed (lane 7). Thus, the 30 half of U12 is sufficient for
65K interaction, and nucleotides within positions 104–130 are
required for binding. The latter is unexpected as RRM-con-
taining proteins typically bind single-stranded nucleotides
(Varani and Nagai, 1998) and this region contains predomi-
nantly base-paired nucleotides in the current U12 model.
The 3 0 half of U12 snRNA can adopt an alternative
structure
To determine whether alternative structures of the human
U12 snRNA might exist, putative secondary structures were
generated using the MFOLD prediction program (Zuker,
2003). Indeed, the most energetically favorable U12 structure
generated differed considerably in its 30 half (but not 50 half)
from that proposed by Wassarman and Steitz (1992). That is,
SLIII and IV were replaced by a single extended SL structure
containing a 7-nt loop (Figure 5A). Strikingly, the terminal
hairpin contains nucleotides required for 65K binding. In
contrast, the structure of the human U2 snRNA predicted
by the MFOLD program did not differ significantly from the
published one (not shown).
Previous chemical/enzymatic structure probing of human
U12 snRNA provide limited information about the structure
of its 30 half (Wassarman and Steitz, 1992), but the results
obtained are consistent with both the previously proposed
U12 structure and that generated by MFOLD. To obtain
additional structural information, in vitro-transcribed U12
snRNA was incubated with increasing concentrations of
lead acetate and cleavage sites were identified by primer
extension analyses (Figure 5B). At higher lead concentra-
tions, nt 114–120 and A102 were cleaved, as evidenced by an
increase in reverse transcriptase stops at these positions
(lanes 8–10). Similar results were obtained with endogenous
U12 snRNA purified from HeLa U12 snRNPs (not shown).
As lead(II) ions specifically cleave phosphodiester bonds
of single-stranded nucleotides (Brunel and Romby, 2000),
these results support the existence of the 7-nt loop at posi-
tions 114–120 (Figure 5C). In contrast, in the published U12
structure, four of these nucleotides are base-paired and thus
should not be cleaved. Additional primer extension analyses
also revealed cleavage sites at A89 and A90 (not shown).
Significantly, only one of 5 nt comprising loop III in the
published structure (i.e., A102) (Figure 5D) was cleaved
(Figure 5B, lanes 7–10). Owing to their proximity to the
30 end of U12, only a subset of nucleotides proposed to
comprise loop IV (i.e., nt 130–133) could be analyzed.
Significantly, no cleavage was observed at these positions
(Figure 5B, lanes 7–10). These data provide additional
evidence that the 30 half of human U12 folds into a single
stem with a 7-nt terminal loop.
A single, extended 3 0 SL is an evolutionarily conserved
feature of U12 snRNA
In addition to humans, U12 snRNAs have been identified in a
number of organisms including Mus musculus, Gallus gallus,
Xenopus laevis, A. thaliana and D. melanogaster (Shukla and
Padgett, 1999; Otake et al, 2002). We have identified putative
U12 snRNAs from Pan troglodytes (chimp), Oryza sativa (rice),
Apis mellifera (honeybee), Anopheles gambiae (mosquito),
Drosophila pseudoobscura (fruit fly), Fugu rubripes (pufferfish)
and Ciona intestinalis (sea squirt) by performing BLAST
searches with the human U12 snRNA. Putative structures of
the 30 half of U12 from various organisms were generated by
the MFOLD program; a subset of these is shown in Figure 6A.
Significantly, the 30 halves of all U12 snRNAs identified to date
theoretically adopt a similar conformation, namely a single
SL containing a 7-nt (or 8-nt in case of A. thaliana and
D. pseudoobscura) loop. The length and sequence of the 30
stem, as well as the nature and number of internal loops,
varies. However, 4 nt of the loop (i.e., UACYU ) and the loop-
closing C-G base pair are 100% conserved (Figure 6B). An
alignment of the loop and adjacent stem nucleotides yields the
loop consensus sequence YUACYUY, where Y is a pyrimidine.
Thus, an extended 30 SL with a conserved loop appears to be
a common feature of all U12 snRNAs.
U11/U12-65K binds the 7-nt loop of the extended
3 0 SL of U12
To determine whether 65K binds the terminal loop of the 30
SL of U12, we chemically synthesized nt 109–125 of human
U12, which comprise the 7-nt loop plus a five base pair stem
(Figure 7A; designated U12wt oligo). Indeed, 32P-labeled
U12wt oligo was precipitated more efficiently than a control
oligonucleotide (the complementary sequence of U12wt) by
both GST-65K and GST-65K-C-RRM (but not GST) in GST
pulldowns, indicating that this region of U12 serves as the
65K binding site (Figure 7B). EMSAs with GST-65K-C-RRM
or GST-65K-C-half and 32P-labeled U12wt oligo or full-length
U12 snRNA were subsequently performed. Owing to its
inefficient expression and instability in Escherichia coli, full-
length recombinant 65K protein could not be used in these
studies. The apparent KD of both GST fusion proteins with
Dual binding activity of the U11/U12-65K protein
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Figure 5 The 30 half of U12 snRNA can adopt an alternative structure. (A) Secondary structure of the human U12 snRNA as proposed by
Wassarman and Steitz (1992) (left) or generated by the MFOLD secondary structure prediction program (right). Nucleotides required for 65K
binding are indicated by a line. (B) Lead(II)-induced cleavage of human U12 snRNA. Primer extension was performed after treatment of
in vitro-transcribed U12 snRNA with 0, 1, 5, 10 and 50 mM lead acetate (lanes 6–10) using a primer complementary to nt 139–150. A sequencing
ladder (lanes 2–5) was generated by performing primer extension of U12 snRNA in the presence of dideoxynucleotides. Lane 1: reaction
without ddNTPs. Nucleotide positions are indicated on the right. Summary of cleaved sites in the alternative (C) or previously published (D) 30
half structure of human U12 snRNA. Weak (open arrowheads) and strong (closed arrowheads) cleavage sites are indicated.
Dual binding activity of the U11/U12-65K protein
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full-length U12 (i.e., protein concentration required for 50%
complex formation) was 0.5 mM (Figure 7C, lanes 5–11; not
shown), which is within the range typically observed for
RRM-containing proteins (i.e., 1011–106 M; Varani and
Nagai, 1998). In contrast, the apparent KD observed with
the U12wt oligo was 10mM for GST-65K-C-RRM (Figure 7C,
lanes 1–4) and greater than 30mM for GST-65K-C-half (not
shown), indicating anB20-fold higher affinity of 65K for full-
length U12. Consistent with these results, in competition
studies, a much higher excess of the U12wt oligo (B10-
fold), as compared to the U12 snRNA, was required to
compete out complex formation between 65K-C-RRM and
U12 snRNA (not shown). Removal of GST or extending the
stem of U12wt oligo by two base pairs (to stabilize the
hairpin) had little or no effect on 65K binding affinity (not
shown). These results indicate that nucleotides comprising
the loop and adjacent stem of the extended 30 SL of U12 are
recognized by the 65K protein, but that additional U12
nucleotides contribute to 65K binding affinity.
To determine which nucleotides of the 30 loop and adjacent
stem are required for 65K binding, we mutated one or more
nucleotides of the U12wt oligo (Figure 7A) and performed
EMSAs with GST-65K-C-RRM. Mutation of conserved loop
nucleotides U115, A116 and C117 (i.e., exchanging a pyrimi-
dine with a purine and vice versa; mutants L1, L2 and L3)
abolished 65K–RNA complex formation (Figure 7D, lanes
9–20). Conversion of the conserved C-G loop-closing base
pair to U-A (mutant S1) severely reduced complex formation
(lanes 21–24). Disruption of the stem (mutant S2) nearly
abolished complex formation (lanes 25–28) indicating that,
like U1-A and U2-B00, an SL structure, and not single-stranded
RNA alone, is required for binding. Changing the orientation
of the loop-closing C-G base pair to a G-C base pair (mutant
S4) had only a moderate effect, whereas altering the entire
Figure 6 An extended 30 SL in U12 snRNA is evolutionarily conserved. (A) Predicted secondary structures of the 30 half of U12 from various
organisms (as indicated) were generated by the MFOLD program. (B) Phylogenetic comparison of nucleotides comprising the terminal loop
and adjacent stem of the 30 SL of U12.
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sequence of the stem (S3) nearly abolished binding (lanes 29–
36). However, altering all stem nucleotides with the exception
of the C-G loop-closing base pair (mutant S5) had no effect
(lanes 37–40). Thus, an SL structure, as well as the identity of
several of the loop nucleotides and the loop-closing base pair,
plays a critical role in the 65K/30 SL interaction.
An excess of the U12wt oligo inhibits U12-dependent
splicing in vitro
To investigate the role of the 65K–U12 snRNA interaction in
U12-dependent pre-mRNA splicing, splicing was carried out in
HeLa nuclear extract with 32P-labeled U12-type P120 pre-mRNA
in the presence of a molar excess (relative to U12) of the U12wt
or S5 mutant oligonucleotides, both of which efficiently bind
65K (Figure 7D). Addition of these oligonucleotides is expected
to compete for 65K binding and functionally sequester it in the
splicing reaction. L3, which contains a single point mutation
that abolishes 65K binding, was also used to control for
nonspecific effects of oligonucleotide addition. As shown in
Figure 8A, addition of 100 or 150 pmol of U12wt and S5
oligonucleotide led to a reduction in splicing as evidenced by
a drop in the level of mRNA and spliced intron. In contrast, L3
had little effect on splicing even at the highest concentration
tested. Quantitation with a phosphorimager revealed a 50–60%
reduction in the level of mRNA relative to pre-mRNA in the
presence of U12wt and S5 (Figure 8B). Significantly, addition of
the U12wt oligo had no effect on splicing of a U2-type pre-
mRNA (not shown). These studies suggest that the 65K protein
plays an important role in U12-dependent splicing.
The N-terminal half of the U12-65K protein interacts
with the U11-59K protein
To identify potential protein interaction partners of the 65K
protein, we first performed two-hybrid interaction assays in
Figure 7 The 65K protein binds the terminal hairpin of the extended 30 SL of U12. (A) Sequence of the wild-type U12 SL oligonucleotide
(U12wt) and mutants (L1–L3 and S1–S5). Altered nucleotides are highlighted in black. The relative affinity of 65K-C-RRM for each mutant is
indicated by plusses or a minus. (B) 65K and 65K-C-RRM interact with U12wt in GST pulldowns. (C) EMSA of 65K-C-RRM with U12wt oligo
versus full-length U12 snRNA. Increasing concentrations of GST-65K-C-RRM (as indicated above each lane) were incubated with 0.01 or
0.25 pmol of the indicated oligonucleotide (lanes 1–4) or RNA (lanes 5–11), respectively. RNP complex formation was analyzed by native gel
electrophoresis and visualized by autoradiography. Note that similar results were obtained when equimolar amounts (10mM each) of U12wt
oligo and U12 snRNA were used. (D) Effect of U12wt oligo mutation on 65K-C-RRM interaction. 32P-labeled oligos (as indicated above) were
incubated with increasing concentrations of GST-65K-C-RRM (0, 5, 10 or 25mM) and analyzed as in panel C.
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yeast. When 65K was used as bait, it interacted strongly with
59K but not with any of the other U11/U12-specific proteins
tested (not shown). This interaction was also observed in the
reciprocal two-hybrid screen with 59K as bait (Figure 9A),
indicating that both proteins tightly interact with one another.
To further define the interacting domains of 65K and 59K,
deletion mutants were generated. 65K1–257 and 65K257–517
consist of 65K’s N-terminal RRM plus the proline-rich region
(aa 1–257) or its C-terminal RRM plus upstream amino acids
(aa 257–517), respectively (Figure 9D). 59K was divided into
its N-terminal proline-rich region (59K1–135), arginine-rich
region (59K130–337) and C-terminal region rich in glutamic
acid (59K332–481). When 59K was used as bait, it interacted
with full-length 65K and 65K1–257, but not with 65K257–517
(Figure 9A). When the 59K deletion mutants were used as
bait, interactions were only observed between 59K332–481 and
either full-length 65K or 65K1–257. Significantly, no interaction
was observed between 59K332–481 and the U11/U12-specific
35K, 25K or 20K proteins when used as either bait or fused to
the activating domain (not shown). These results indicate
that the N-terminal half of 65K interacts specifically with the
C-terminal 149 aa of the 59K protein.
Next, Far Western overlays were performed with in vitro-
translated, 35S-labeled U11/U12 proteins and nitrocellulose
strips containing U11/U12 proteins. Interestingly, both full-
length 65K and 65K1–257 (Figure 9B, lanes 2 and 3), but not
65K257–517 (not shown), interacted predominantly with 59K.
The 65K–59K interaction appears to be specific, as other
equally abundant proteins (as evidenced by Ponceau stain-
ing; Figure 9B, lane 1) were not efficiently bound by 65K.
Furthermore, in vitro-translated 35K or 20K protein did not
react with 59K in Far Western overlays (not shown). Owing to
the extremely high GC-rich 50 end of the 59K cDNA, it was not
possible to translate full-length 59K in vitro or overexpress
it, thereby preventing overlays or GST pulldowns. However,
in vitro-translated 59K332–481 reacted specifically with 65K
(Figure 9B, lane 4), consistent with the 65K1–257/59K332–481
interaction observed by two-hybrid assays.
Finally, pulldowns were performed with GST fusions con-
taining full-length or truncated 65K, and in vitro-translated,
35S-labeled 59K332–481. Co-precipitated protein was subse-
quently analyzed by SDS–PAGE. Significantly, 59K332–481
was precipitated efficiently with GST-65K and GST-65K-N-
half, but not with GST, GST-65K-N-RRM, GST-65K-C-half or
GST-65K-C-RRM (Figure 9C). These results demonstrate that
the N-terminal half of 65K interacts with the C-terminal
149 aa of 59K and further suggest that residues between
positions 150–257 of 65K are required for this interaction.
Discussion
65K binds the terminal hairpin of the 3 0 SL of U12
We have investigated protein–RNA and protein–protein interac-
tions involving proteins specifically associated with the human
18S U11/U12 snRNP. We show that the U11/U12-65K protein
directly interacts with the U12 snRNA (Figures 2 and 4). These
data provide the first information about proteins that directly
contact snRNA within the U11/U12 snRNP. Co-IP studies with
truncated U12 snRNA revealed that the 65K binding site is
located in the 30 half of U12 (Figure 4). We provide evidence
that, in contrast to the currently accepted structure, the 30 half of
the human U12 snRNA folds into a single, extended SL with a
terminal 7-nt loop. Evidence for the 30 SL structure includes the
following: (i) all known U12 snRNAs from diverse organisms,
including vertebrates, plants and insects, can theoretically be
folded into this structure and it represents the most energetically
favorable in each case; (ii) structure probing studies with
lead(II) ions (Figure 5) were most consistent with the 30 SL
structure; and (iii) the sequence of the terminal loop of the 30 SL
is evolutionarily highly conserved (Figure 6) and a chemically
synthesized RNA oligo comprising the terminal hairpin binds
recombinant 65K both in GST pulldowns and EMSAs (Figure 7).
The latter result not only supports the existence of the
extended 30 SL, but also precisely maps the binding site of
65K on the U12 snRNA to nucleotides comprising the term-
inal hairpin. Mutational analyses demonstrated that the
nature of the loop nucleotides and the loop-closing base
pair, and also the existence of a stem structure are major
determinants of 65K binding (Figure 7). The U1-A and U2-B00
proteins also require a hairpin structure for binding and
recognize not only loop nucleotides, but also the loop-closing
base pair of their respectively bound RNA hairpins in a
sequence-specific manner (Oubridge et al, 1994; Price et al,
1998). In the case of U1-A and U2-B00, the presence of a stem
is thought to aid binding, not only through sequence-specific
interactions, but also by imposing constraints on the con-
formation of the loop nucleotides (Varani and Nagai, 1998).
Significantly, although nucleotides comprising the terminal
loop of the 30 SL of U12 are also partially single stranded in
Figure 8 An excess of U12wt and S5 oligo inhibits P120 pre-mRNA
splicing in vitro. (A) In vitro splicing was performed for 4 h with 32P-
labeled P120 pre-mRNA in the presence of increasing concentra-
tions (as indicated) of U12wt oligo (lanes 4–7), mutant L3 oligo
(lanes 8–11) or mutant S5 oligo (lanes 12–15). Lanes 1–3: P120
splicing in the absence of oligo after 0, 2 and 4 h. RNA was
separated on an 8% polyacrylamide–8 M urea gel and visualized
by autoradiography. The positions of the splicing intermediates and
products are indicated schematically on the left. (B) Quantitation of
splicing efficiency. The amounts of pre-mRNA and mRNA were
determined using a PhosphorImager and the ratio of mRNA to pre-
mRNA was plotted as a function of oligonucleotide concentration.
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the previously published U12 structure (i.e., they are located
between stems III and IV), the requirement of a hairpin
structure for 65K binding argues against the existence of
the latter structure in the U11/U12 snRNP.
The 65K C-terminal RRM deletion mutant binds U1
and U2 snRNA as well as U12
Data presented here demonstrate that the C-terminal RRM of
65K is necessary and sufficient for U12 binding. However, in
contrast to full-length 65K or 65K-C-half (aa 211–517), 65K-C-
RRM (aa 380–517) also interacted with U1 and U2, but not
U11, U4 or U5. Thus, in the absence of residues 211–379, 65K
loses its ability to distinguish between the U1, U2 and U12
snRNAs, but retains some binding specificity in that other
snRNAs are not bound. By analogy, in the absence of the
U2-A0 protein, U2-B00 lacks the ability to distinguish between
U1 and U2, binding both with similar affinity (Bentley
and Keene, 1991). A comparison of the cocrystals of the
Figure 9 The N-terminal half of 65K interacts with the C-terminal 149 aa of the 59K protein. (A) Yeast two-hybrid assays with the 65K and 59K
proteins (and deletion mutants thereof). (B) 65K and 59K interact in Far Western overlays. U11/U12 proteins on nitrocellulose strips were
visualized by staining with Ponceau S (lane 1) or incubated with 35S-labeled, in vitro-translated protein (as indicated above each lane) and
visualized by fluorography (lanes 2–4). U11/U12 proteins are indicated on the left. (C) GST pulldowns with 35S-labeled 59K332–481 and GST
(lane 2), or GST fusions of 65K and deletion mutants thereof (lanes 3–7; as indicated). Co-precipitated protein or 10% of the input (lane 1) was
analyzed by SDS–PAGE and visualized by fluorography. (D) Schematic of wild-type and truncated 65K and 59K proteins used in panels A–C.
Abbreviations are as in Figure 2. Arginine- (Arg) and glutamic acid-rich regions (Glu) are shaded gray.
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N-terminal RRM of U1-A and U2-B00 bound to U1 SLII and U2
SLIV, respectively, indicates that snRNA discrimination by
U1-A and U2-B00 is the result of the formation of a different
network of multiple hydrogen-bonding interactions between
the RNA and protein (Oubridge et al, 1994; Price et al, 1998).
Presumably, the structure of the C-terminal RRM mutant, in
contrast to the full-length protein or the C-terminal half
mutant, is altered in some way such that it is capable of
engaging in a network of interactions compatible not only
with U12 but also U1 and U2 binding.
The U11/U12-65K and U1-A/U2-B 00 proteins appear
to be related
Among human proteins present in the NCBI nr database, the
C-terminal RRM of 65K exhibits the second highest degree of
homology with the N-terminal RRM of U1-A and U2-B00. This
finding, as well as the ability of 65K-C-RRM to recognize U1
and U2, suggests that these proteins may have evolved from a
direct common ancestor or potentially from one another.
Significant homology between the RRM of the U11-35K
protein and that of the U1-70K protein, which also binds U1
snRNA, was noted previously (Will et al, 1999), suggesting
that several U11/U12-specific proteins may be evolutionarily
related to U1 or U2 proteins.
The RRM is an ancient domain and, because of its modular
nature, RRM proteins have been proposed to have evolved
by gene duplication of an ancestral RNA binding protein
and subsequent diversification (Bandziulis et al, 1989). The
N-terminal RRM of 65K does not exhibit notable homology
with its own C-terminal RRM, indicating that the N- and
C-terminal RRMs have not arisen by an intragenic domain
duplication event. Likewise, the N- and C-terminal RRMs of
U1-A or of U2-B00 do not appear to be related by RRM
duplication within the same protein (Birney et al, 1993).
The N-terminal RRM of the 65K protein also does not exhibit
notable homology with the C-terminal RRMs of U1-A or
U2-B00. This, coupled with the fact that the position of the
related RRMs is different in 65K versus U1-A/U2-B00 (i.e.,
C- versus N-terminal), suggests that if in fact the 65K C-
terminal RRM was duplicated giving rise to U1-A/U2-B00
(or vice versa) it must have been inserted into an unrelated
protein already containing a second RRM. Alternatively, after
gene duplication, unrelated RRMs must have been introduced
into the N- or C-terminus of the 65K or U1-A/U2-B00 proteins,
respectively. Although less likely, it cannot be excluded that
the observed homology between the C-terminal RRM of 65K
and the N-terminal RRM of U1-A/U2-B00 is fortuitous in nature.
Three models describing potential evolutionary relation-
ships between the U2- and U12-type spliceosomes have been
proposed (Burge et al, 1998). These include the so-called
fission–fusion and codivergence models, in which both spli-
ceosomes have a homologous origin (i.e., they are derived
from a common ancestor). The apparent relatedness of 65K
and U1-A/U2-B00 is consistent with a homologous origin of
the major and minor spliceosomes. The latter is also sup-
ported by the fact that many spliceosomal proteins and the
U5 snRNA are shared by both spliceosomes. However, the
limited sequence similarities between the U11, U12, U4atac
and U6atac snRNAs and their major snRNA counterparts
suggest that they have a nonhomologous origin and thus
support the so-called parasitic invasion model. In this model,
several genes of a common ancestor of animals and plants,
which had a pre-existing spliceosome, were invaded by a
parasitic group II intron. Fragmentation of this intron gave
rise to new snRNAs that associated with many proteins of the
pre-existing spliceosome, resulting in snRNPs with shared or
similar proteins. In the case of 65K, a pre-existing protein that
recognized the U2 snRNA may have evolved such that it also
recognized the U12 snRNA (or vice versa); at some point in
time, the full-length protein would have lost its ability to
recognize U2 (or U12), thereby preventing the formation of
hybrid U2 and U12 snRNPs. Thus, data presented here also
support the idea that a subset of snRNP proteins from one of
the spliceosomes directly diverged from proteins of the other
pre-existing spliceosome.
U12-65K interacts with the U11-59K protein
Data presented here also provide the first insights into
protein–protein interactions that likely contribute to U11/
U12 snRNP formation. Yeast two-hybrid, Far Western and
co-IP assays demonstrated a direct interaction between the
65K and 59K proteins. The latter, in contrast to 65K, which
binds the U12 snRNA, is associated with 12S U11 snRNPs.
Thus, the 65K–59K interaction appears to bridge 12S U11 and
15S U12 snRNPs, and may play a key role in the biogenesis of
the 18S U11/U12 di-snRNP. Importantly, the region of 65K
that interacts with 59K was mapped to aa 150–257 in its N-
terminal half, which are not involved in U12 binding. Interes-
tingly, this region contains the sequence QVLHLMN(K/
R)MNL, which is 100% conserved and uniquely present in
all putative 65K orthologs identified to date. Truncation of
59K revealed that aa 332–481 at its C-terminus are involved in
65K binding. That this region of 59K is located at the U11/U12
interface was suggested previously by IP studies in which
antibodies against the C-terminus of the protein precipitated
12S U11 but not U11/U12 snRNPs (Will et al, 2004). The U11
snRNP does not appear to remain associated with U12
throughout the course of splicing, but rather is likely desta-
bilized during catalytic activation of the spliceosome. Thus,
U11 and U12 snRNPs appear to be reassembled after each
round of splicing, and interactions mediating di-snRNP for-
mation may repeatedly play a crucial role in splicing. In this
respect, it is also interesting to note that 59K (also denoted
ES18) has been implicated in apoptosis (Park et al, 1999),
suggesting that the disruption of U11/U12 di-snRNP forma-
tion is potentially linked to programmed cell death.
The concomitant interaction of the U11/U12 di-snRNP with
the 50 splice site and branch site of the pre-mRNA during U12-
dependent prespliceosome assembly indicates that U11/U12
proteins contribute to intron bridging at this stage. Although
direct evidence is currently lacking, the U11/U12-specific 65K
and 59K proteins likely play an important role in this process.
In the major spliceosome, SR proteins have been implicated
in intron bridging interactions and recent data suggest that
the DEAD-box protein Prp5 bridges the U1 and U2 snRNPs
(Xu et al, 2004). SR proteins are required for U12-type
splicing and likely facilitate interactions of the U11/U12
snRNP with the pre-mRNA (Hastings and Krainer, 2001),
but they do not appear to function in di-snRNP formation/
stability (i.e., they are not found in purified U11/U12
snRNPs). Likewise, hPrp5 is not part of the human 18S
U11/U12 snRNP and thus does not appear to contribute to
intron bridging interactions in the minor prespliceosome.
Thus, unique protein–protein interactions, including
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65K-59K, likely contribute to the molecular bridge connecting
the ends of an U12-type versus U2-type intron.
A functional role for 65K in U12-dependent splicing
A vital cellular function of the 59K protein was previously
demonstrated by RNAi-mediated knockdowns, which led to
cell death (Will et al, 2004). However, the significant amount
of 59K still present after knockdown (B30%) and the in-
ability to efficiently immunodeplete 59K from HeLa nuclear
extract have hindered studies of its role in di-snRNP forma-
tion. Likewise, owing to inefficient RNAi-mediated knock-
down and immunodepletion of 65K, its role in splicing and/
or di-snRNP formation could not be assayed by these meth-
ods. As an alternative approach, we attempted to functionally
sequester the 65K protein by adding a large molar excess of
the U12wt oligonucleotide comprising the 65K binding site;
similar studies revealed a role for the U4-15.5K RNA binding
protein in U2-type splicing (Nottrott et al, 1999).
Significantly, addition of the U12wt oligo led to a reduction
in the efficiency of U12-type (but not U2-type) splicing
in vitro (Figure 8; not shown). The effect of the U12wt
oligo appeared to be specific, as no reduction in splicing
was observed with a mutant U12 oligonucleotide (L3) that no
longer binds 65K. In the presence of the U12wt oligo, a
significant reduction in U11/U12 di-snRNP formation could
not be detected by IP studies (not shown), suggesting that the
observed reduction in splicing is not due to disruption of
the di-snRNP complex. However, more subtle alterations in
the molecular architecture of the U11/U12 snRNP upon
U12wt oligo addition or a more direct role of the 65K protein
in U12-dependent splicing cannot, at present, be ruled out.
Materials and methods
Database searches
Homologs of the human 65K protein and U12 snRNAs were
identified by BLASTsearches of the nr or EST databases at the NCBI
(http://www.ncbi.nlm.nih.gov/entrez/). Proteins were aligned
using the Clustal method.
In vitro transcription and 5 0-end labeling of RNA
32P-labeled U1, U2, U11 or U12 snRNA was transcribed in vitro with
T7 or SP6 polymerase from plasmids containing the respective
snRNA gene in the presence of 32P-UTP (3000 Ci/mmol). Prepara-
tive amounts of m7G-capped, nonlabeled UsnRNA (for co-IPs) were
prepared under similar conditions, except that m7GpppG was
included in the reaction. RNA oligonucleotides were 50-end labeled
with polynucleotide kinase and [g-32P]ATP (5000 Ci/mmol).
Co-IP studies and GST pulldowns
Co-IPs with anti-cap antibodies were performed essentially as
described by Nottrott et al (1999). GST fusion proteins or GST alone
were expressed in E. coli (BL21 plysS) cells and purified as described
previously (Will et al, 2001). For mobility shift assays, GST-65K-C-half
was subsequently concentrated using a Vivaspin concentrator
(Vivascience) according to the manufacturer’s protocol. GST pull-
downs were performed with the indicated in vitro–transcribed, 32P-
labeled UsnRNA, 32P-end-labeled RNA oligo or 6ml of in vitro-
translated, 35S-labeled 59K332–481 protein essentially as described (Will
et al, 2001). To isolate co-precipitated UsnRNAs, 100ml of 1 PK
buffer (100 mM Tris–HCl (pH 7.5), 12.5 mM EDTA (pH 8.0), 150 mM
NaCl, 1% (w/v) sodium dodecyl sulfate) were added, followed by
phenol extraction and ethanol precipitation. RNA was separated on a
10% polyacrylamide–7 M urea gel. Co-precipitated protein was
analyzed as described above. Pulldown of oligonucleotides was
quantitated by Cherenkov counting in a scintillation counter.
Lead(II)-induced cleavage
U12 snRNA was isolated by phenol extraction from purified
UsnRNPs or generated by in vitro transcription. 50 ng in vitro-
transcribed U12 and 2 mg tRNA were incubated for 5 min at 201C in
20ml of buffer N1 (25 mM HEPES–NaOH (pH 7.5), 5 mM magne-
sium acetate, 100 mM potassium acetate) in the presence of 0, 1, 5,
10 or 50 mM lead(II) acetate according to Brunel and Romby (2000).
Reactions were stopped by adding 5ml of 250 mM EDTA and RNAs
were recovered by ethanol precipitation. Cleavage sites were
detected by primer extension with primers complementary to nt
139–150 of U12 as described by Hartmuth et al (1999).
Electrophoretic mobility shift assays
Recombinant proteins (0–100 pmol, as indicated) were incubated with
0.25 pmol of 32P-end-labeled RNA oligonucleotide or 0.01 pmol of 32P-
labeled, in vitro-transcribed UsnRNA for 45 min at 41C in the presence
of 10mg of E. coli tRNA in a final volume of 10ml of buffer A (20 mM
HEPES–KOH (pH 7.9), 100 mM KCl, 1.5 mM MgCl2, 20mg/ml of E. coli
tRNA, 0.25 mM DTE, 5% glycerol, 10mg/ml BSA). RNA–protein
complexes were separated on a native 6% (80:1) polyacrylamide gel.
Far Western overlays and yeast two-hybrid assays
Coupled transcription and translation of the indicated protein were
performed using the TNT system (Promega) in the presence of
[35S]methionine (1000 Ci/mmol). For Far Westerns, 18S U11/U12
snRNP proteins were isolated by affinity selection with a biotinylated
oligonucleotide complementary to U12 and streptavidin agarose beads
(Will et al, 1999). Proteins were separated on a 13% polyacrylamide–
SDS gel, transferred to nitrocellulose and visualized by staining with
Ponceau S. Far Western overlays were performed as described by
Achsel et al (1998). Yeast two-hybrid analyses were performed with
the MATCHMAKER Two-Hybrid System 3 as described by the
manufacturer (Clontech) (see also Supplementary data).
In vitro splicing
Splicing was performed with in vitro-transcribed, 32P-labeled P120
pre-mRNA essentially as described previously (Will et al, 2001),
except that U2-type splicing was inhibited by adding a 20Ome RNA
oligo complementary to the U6 snRNA (AUGCUAAUCUUCUCU
GUA; end concentration 4.8 mM). For splicing inhibition studies,
increasing concentrations (10–150 pmol) of U12wt, L3 and S5 oligo
were added to a standard 12.5ml splicing reaction. RNA was
recovered by phenol–chloroform extraction and ethanol precipita-
tion, fractionated on an 8% polyacrylamide–8 M urea gel and
visualized by autoradiography. Quantitation of splicing efficiency
was performed with a PhosphorImager (Molecular Dynamics).
Supplementary data
Supplementary data are available at The EMBO Journal Online.
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